Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
First field complaint received 05 may 11 from poole hospital nhs foundation uk. receipt of rsrx product that was observed to measure approximately 16% below the activity stated within the associated i-125 sealed source calibration certificate (0.449 mci). second field complaint received may 18 from san sebastian where the calibration strand was assayed and activity found to deviate from label by 8.3%. two additional complaints were the orders determined to be mixed with poole and san sebastian.